<i>N</i>MR<sup>2</sup>-Based Drug Discovery Pipeline Presented on the Oncogenic Protein KRAS
Article Details
Journal Info
Journal of the American Chemical Society
American Chemical Society
Authors (9)
Matthias Bütikofer
Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, 2F 353, Vienna, A-1090, Austria
Felix Torres
Institute for Molecular Physical Science, Vladimir Prelog Weg 2, Zürich, 8093, Switzerland
Harindranath Kadavath
Institute for Molecular Physical Science, Vladimir Prelog Weg 2, Zürich, 8093, Switzerland
Nina Gämperli
Institute for Molecular Physical Science, Vladimir Prelog Weg 2, Zürich, 8093, Switzerland
Marie Jose Abi Saad
Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, 2F 353, Vienna, A-1090, Austria
Daniel Zindel
Institute for Molecular Physical Science, Vladimir Prelog Weg 2, Zürich, 8093, Switzerland
Nicolas Coudevylle
Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, 2F 353, Vienna, A-1090, Austria
Roland Riek
Institute for Molecular Physical Science, Vladimir Prelog Weg 2, Zürich, 8093, Switzerland
Julien Orts
Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, 2F 353, Vienna, A-1090, Austria